In hepatocellular carcinoma, miR-186 inhibits self-renewal of hepatocellular carcinoma stem cells and is more sensitive to cisplatin treatment by binding to 3’-UTR of PTPN11 mRNA and reducing its expression (247). This evidence concerns the gene PTPN11 and hepatocellular carcinoma.